/ /

Glaucoma

No strategies exist to lower glaucoma risk; healthy habits offer starting pointAlthough there are no scientifically proven ways to prevent glaucoma, healthy habits–such as moderate exercise, regular visual check-ups, and eating green, leafy vegetables–represent a good starting point for a prevention strategy.
Investigating strains on ONH tissue key to unraveling mystery of glaucomaInvestigations of the biomechanical changes in the optic nerve head may eventually lead to improvements in therapies for patients with glaucoma.
Novel glaucoma drugs close at handA review of glaucoma drugs in various clinical study phases reveals that at least seven new glaucoma drugs were in trials and two others were approved by the FDA in 2017. Many drugs that have progressed the most act on prostaglandin receptors, though some combine this with other mechanisms of action.
New glaucoma therapy offers first drug option in years
Glaucoma experiences transformative growth as a subspecialtyAfter decades of slow, but steady, progress in the advancement of glaucoma as a subspecialty, the last quarter century has seen tremendous innovation in this field.
B+L, Nicox announce studies of glaucoma drugBausch + Lomb has initiated its phase III clinical program of latanoprostene bunod (licensed by Nicox S.A.) for the reduction of IOP in glaucoma or ocular hypertension.